Adaptive Biotechnologies Corp

詳細情報企業名

企業情報

企業コードADPT

会社名Adaptive Biotechnologies Corp

上場日Jun 27, 2019

最高経営責任者「CEO」Mr. Chad M. Robins

従業員数619

証券種類Ordinary Share

決算期末Jun 27

本社所在地1165 Eastlake Ave E

都市SEATTLE

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号98109

電話番号12066590067

ウェブサイトhttps://www.adaptivebiotech.com

企業コードADPT

上場日Jun 27, 2019

最高経営責任者「CEO」Mr. Chad M. Robins

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Chad M. Robins

Chairman of the Board, Chief Executive Officer, Co-Founder

2.10M

-4.49%

Ms. Susan Bobulsky

Chief Commercial Officer - MRD

347.24K

+37.09%

Mr. Francis Lo

Chief People Officer

332.85K

+31.17%

Mr. Peter M. Neupert

Lead Independent Director

209.30K

+8.24%

Dr. Sharon Benzeno, Ph.D.

Chief Commercial Officer - Immune Medicine

95.93K

-15.18%

Dr. Katey Einterz Owen, Ph.D.

Independent Director

57.23K

+42.41%

Dr. Robert M. (Rob) Hershberg, M.D., Ph.D.

Independent Director

54.30K

+41.54%

Mr. Kyle Piskel

Chief Financial Officer

47.39K

-3.91%

Ms. Karina Calzadilla

Vice President - Investor Relations

--

Ms. Julie Rubinstein

President, Chief Operating Officer

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Chad M. Robins

Chairman of the Board, Chief Executive Officer, Co-Founder

2.10M

-4.49%

Ms. Susan Bobulsky

Chief Commercial Officer - MRD

347.24K

+37.09%

Mr. Francis Lo

Chief People Officer

332.85K

+31.17%

Mr. Peter M. Neupert

Lead Independent Director

209.30K

+8.24%

Dr. Sharon Benzeno, Ph.D.

Chief Commercial Officer - Immune Medicine

95.93K

-15.18%

Dr. Katey Einterz Owen, Ph.D.

Independent Director

57.23K

+42.41%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

MRD revenue

43.72M

83.37%

Immune meidicine revenue

8.72M

16.63%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

MRD revenue

43.72M

83.37%

Immune meidicine revenue

8.72M

16.63%

株主

更新時刻: Mon, Sep 22

株主統計

種類

株主統計

比率

Viking Global Investors LP

19.70%

The Vanguard Group, Inc.

7.39%

BlackRock Institutional Trust Company, N.A.

7.27%

Rubric Capital Management LP

4.11%

Amova Asset Management Co., Ltd.

2.82%

他の

58.71%

株主統計

比率

Viking Global Investors LP

19.70%

The Vanguard Group, Inc.

7.39%

BlackRock Institutional Trust Company, N.A.

7.27%

Rubric Capital Management LP

4.11%

Amova Asset Management Co., Ltd.

2.82%

他の

58.71%

種類

株主統計

比率

Investment Advisor/Hedge Fund

44.88%

Investment Advisor

35.69%

Hedge Fund

13.75%

Individual Investor

2.65%

Research Firm

2.02%

Venture Capital

0.96%

Bank and Trust

0.31%

Pension Fund

0.27%

Endowment Fund

0.14%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

498

148.68M

97.64%

-4.69M

2025Q1

498

156.30M

102.90%

-1.29M

2024Q4

481

143.31M

96.47%

-18.10M

2024Q3

478

143.38M

97.20%

-27.99M

2024Q2

486

149.83M

101.63%

-16.40M

2024Q1

506

146.67M

99.58%

-10.66M

2023Q4

529

145.23M

100.12%

-16.05M

2023Q3

531

142.64M

98.54%

-11.65M

2023Q2

545

137.84M

95.31%

-15.76M

2023Q1

577

135.96M

94.24%

-11.97M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Viking Global Investors LP

29.99M

19.74%

--

Mar 31, 2025

The Vanguard Group, Inc.

11.12M

7.32%

+428.54K

+4.01%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

9.79M

6.45%

-19.96K

-0.20%

Mar 31, 2025

Rubric Capital Management LP

13.12M

8.63%

-1.48M

-10.15%

Mar 31, 2025

Amova Asset Management Co., Ltd.

6.09M

4.01%

-747.45K

-10.94%

Mar 31, 2025

ARK Investment Management LLC

4.40M

2.9%

-1.67M

-27.51%

May 31, 2025

Braidwell LP

4.80M

3.16%

+4.80M

--

Mar 31, 2025

Geode Capital Management, L.L.C.

2.78M

1.83%

+96.32K

+3.59%

Mar 31, 2025

State Street Global Advisors (US)

2.69M

1.77%

-40.36K

-1.48%

Mar 31, 2025

Aristotle Atlantic Partners, LLC

2.94M

1.94%

+54.51K

+1.89%

Mar 31, 2025

詳細を見る

13.220USD

Adaptive Biotechnologies Corp

13.220

概要

企業名

金融

分析